ReachMD Your single destination for free CMEs, medical news, & more. Be Part of the Knowledge. The compelling broadcast line-up of information and education runs 24/7.

ReachMD is a revolutionary healthcare communications and education network dedicated to helping busy healthcare professionals stay abreast of clinical research, treatment advances, expert opinions, and patient care strategies. Our unique, integrated network leverages peer-to-peer dialogs among medical experts to educate and inform listeners across a wide spectrum of topics. Listeners can 'tune in' to dialogs on iHeart Radio and TuneIn, enjoy online streaming radio, download podcasts, participate in web-enabled segments on ReachMD.com, and access content through the MedicalRadio mobile app. ReachMD's popular format of peer-to-peer dialogs among medical experts hits the mark for busy clinicians: segments are succinct and typically run for 15 minutes, making it convenient for listeners to participate throughout the day and night wherever they are. Both certified and non-certified education are broadcast, with unique mobile access interfaces to receive CME credit. The custom series and medical industry features are the highlight of our platform, and more than 60 unique series cycle through our programming line-up, including Diabetes Discourse™, Lipid Luminations™, CDC Updates, NEJM Summaries, Grand Rounds Nation®, The FDA Voice, Medical Breakthroughs from Penn Medicine, Heart Matters, Women's Health Fridays™, and many more. ReachMD has the brightest minds today in broadcast media. We are healthcare media strategists and healthcare educationalists whose combined expertise makes the ReachMD broadcast network a one-of-a-kind healthcare enterprise.

09/25/2026

The treatment landscape for KRAS G12C–mutated advanced NSCLC is advancing quickly. How can we close the gap between emerging biology and everyday practice?

Gerard A. Silvestri, MD, MS will examine biomarker testing, first-line treatment selection, and strategies to prepare eligible patients for clinical trials in KRAS G12C–mutated advanced NSCLC in this upcoming live virtual broadcast:

"Closing the Gap in First-Line Treatment of KRAS G12C–Mutated Advanced NSCLC: From Biology to Bedside Decisions and Trial-Ready Care"

🗓️ Tuesday, September 30, 2026
🕟 4:30–5:15 PM EDT

Save your seat: https://ow.ly/kyU050ZPTgx

A CME/CE-accredited activity developed by GLC.

09/24/2026

CLL/SLL Treatment Today and Tomorrow: Strategies for Community Care

09/24/2026

Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer

09/24/2026

Push Past in AD: Treatment Escalation in Moderate to Severe Atopic Dermatitis

09/24/2026

What did clinicians value most at WHAV 2025?

When last year's chair, Dr. Barbara Dehn, spoke with attendees about their favorite parts of the conference, two themes came up again and again.

The first was practicality. Clinicians told Dr. Dehn that the pearls they picked up were ones they could bring straight back to their practice.

The second was access. Attendees valued being able to connect with faculty 1-on-1 to talk about complicated cases.

Good news—the cutting-edge clinical pearls and expert conversations are back!

Grab your spot for WHAV 2026 now.

Get tickets for NYC: https://reachmd.com/u/19966

Save your spot in Pasadena: https://reachmd.com/u/19973

How are evolving treatment strategies informing CLL/SLL care? Join distinguished faculty Jennifer R. Brown, MD, PhD, Shu...
09/23/2026

How are evolving treatment strategies informing CLL/SLL care?

Join distinguished faculty Jennifer R. Brown, MD, PhD, Shuo Ma, MD, Mazyar Shadman, MD, MPH for this CME-certified symposium focusing on fixed-duration versus continuous therapy, patient-specific treatment considerations, and emerging evidence that may influence future management approaches.

Reserve your spot: https://ow.ly/6uio50ZNzQ8

A CME/CE-accredited activity developed by GLC.

When managing moderate to severe atopic dermatitis, how do you approach treatment escalation? Join a live virtual webina...
09/23/2026

When managing moderate to severe atopic dermatitis, how do you approach treatment escalation?

Join a live virtual webinar tomorrow to review disease burden, treatment selection, and individualized care. Save your spot: https://ow.ly/9Xvh50ZKXto

A CME/CE-accredited activity developed by GLC.

How do you apply biomarker results to treatment planning in advanced ovarian cancer across different clinical scenarios?...
09/23/2026

How do you apply biomarker results to treatment planning in advanced ovarian cancer across different clinical scenarios?

Last chance to join expert faculty for a live tumor board as they examine interactive patient cases, discuss biomarker-informed treatment approaches, review treatment sequencing considerations, and share practical strategies for managing adverse events.

Reserve your spot: https://ow.ly/gYN050ZtALN

Missed WCLC LIVE? Our WCLC 2026 satellite symposium on advanced squamous   after chemoimmunotherapy progression is avail...
09/22/2026

Missed WCLC LIVE? Our WCLC 2026 satellite symposium on advanced squamous after chemoimmunotherapy progression is available virtually. Discover insights from leading faculty on resistance mechanisms, CTLA-4-targeted strategies, and treatment sequencing.

Don't miss these expert perspectives. Register today!

Save your seat: https://ow.ly/G8y850ZPj0L

A CME/CE-accredited activity developed by GLC.

09/21/2026

How do biomarker findings influence treatment decisions across the ovarian cancer continuum?

Join expert faculty for a can't-miss LIVE virtual tumor board featuring interactive case discussions and practical clinical insights.

"Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer"

🗓️ September 24, 2026 | 🕞 3:30–4:30 PM ET

Ritu Salani, MD and Kathleen N. Moore, MD, MS will explore biomarker testing strategies and their role in patient selection, treatment sequencing, and individualized care. They'll also discuss the latest evidence supporting PARP inhibitors, immunotherapy, and antibody-drug conjugates as well as adverse event monitoring and management.

Don't miss out! Save your spot now: https://ow.ly/1cTC50ZPLJX

Address

1301 Virginia Drive Ste 300
Fort Washington, PA
19034

Opening Hours

Monday 8:30am - 5:30pm
Tuesday 8:30am - 5:30pm
Wednesday 8:30am - 5:30pm
Thursday 8:30am - 5:30pm
Friday 8:30am - 5:30pm

Alerts

Be the first to know and let us send you an email when ReachMD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share